QQQ 285.09 (-2.86%)

AAPL 138.31 (-3.35%)

MSFT 255.77 (-1.87%)

FB 178.80 (-8.88%)

GOOGL 2,084.55 (-6.51%)

AMZN 2,063.96 (-4.05%)

TSLA 636.46 (-5.70%)

NVDA 160.82 (-4.83%)

BABA 83.14 (-4.69%)

NIO 14.86 (-7.13%)

AMD 90.83 (-4.46%)

CGC 4.84 (-6.74%)

MU 66.59 (-4.31%)

T 20.78 (+0.19%)

GE 72.63 (-3.75%)

F 12.32 (-3.98%)

DIS 100.76 (-4.79%)

AMC 10.60 (-8.46%)

PFE 52.84 (-0.08%)

PYPL 78.21 (-3.66%)

NFLX 178.85 (-4.58%)

QQQ 285.09 (-2.86%)

AAPL 138.31 (-3.35%)

MSFT 255.77 (-1.87%)

FB 178.80 (-8.88%)

GOOGL 2,084.55 (-6.51%)

AMZN 2,063.96 (-4.05%)

TSLA 636.46 (-5.70%)

NVDA 160.82 (-4.83%)

BABA 83.14 (-4.69%)

NIO 14.86 (-7.13%)

AMD 90.83 (-4.46%)

CGC 4.84 (-6.74%)

MU 66.59 (-4.31%)

T 20.78 (+0.19%)

GE 72.63 (-3.75%)

F 12.32 (-3.98%)

DIS 100.76 (-4.79%)

AMC 10.60 (-8.46%)

PFE 52.84 (-0.08%)

PYPL 78.21 (-3.66%)

NFLX 178.85 (-4.58%)

QQQ 285.09 (-2.86%)

AAPL 138.31 (-3.35%)

MSFT 255.77 (-1.87%)

FB 178.80 (-8.88%)

GOOGL 2,084.55 (-6.51%)

AMZN 2,063.96 (-4.05%)

TSLA 636.46 (-5.70%)

NVDA 160.82 (-4.83%)

BABA 83.14 (-4.69%)

NIO 14.86 (-7.13%)

AMD 90.83 (-4.46%)

CGC 4.84 (-6.74%)

MU 66.59 (-4.31%)

T 20.78 (+0.19%)

GE 72.63 (-3.75%)

F 12.32 (-3.98%)

DIS 100.76 (-4.79%)

AMC 10.60 (-8.46%)

PFE 52.84 (-0.08%)

PYPL 78.21 (-3.66%)

NFLX 178.85 (-4.58%)

QQQ 285.09 (-2.86%)

AAPL 138.31 (-3.35%)

MSFT 255.77 (-1.87%)

FB 178.80 (-8.88%)

GOOGL 2,084.55 (-6.51%)

AMZN 2,063.96 (-4.05%)

TSLA 636.46 (-5.70%)

NVDA 160.82 (-4.83%)

BABA 83.14 (-4.69%)

NIO 14.86 (-7.13%)

AMD 90.83 (-4.46%)

CGC 4.84 (-6.74%)

MU 66.59 (-4.31%)

T 20.78 (+0.19%)

GE 72.63 (-3.75%)

F 12.32 (-3.98%)

DIS 100.76 (-4.79%)

AMC 10.60 (-8.46%)

PFE 52.84 (-0.08%)

PYPL 78.21 (-3.66%)

NFLX 178.85 (-4.58%)

NASDAQ:AVTX

Avalo Therapeutics Income Statement & Balance Sheet

$0.32

+0.01 (+3.19%)

(As of 05/24/2022 10:50 AM ET)

Add

Today's Range: $0.32
▼
$0.33
50-Day Range: $0.25
▼
$0.87
52-Week Range: $0.20
▼
$3.70

Volume: 156 shs
Average Volume: 521,900 shs
Market Capitalization: $36.09 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: 2.12

Avalo Therapeutics (NASDAQ:AVTX) Income Statement, Balance Sheet and Cash Flow Statement

This page was last updated on 5/24/2022 by MarketBeat.com Staff

Web Analytics

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms